chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A 50 year old female student, attending a veterinary school of medicine, who was being treated for pre-exposure prophylaxis, developed diffuse pain on the entire left arm which resulted in a tingling sensation and paresthesia, 24 hours, post vax, of a 2nd pre-exposure dose of RabAvert. Each dose was 1ml and given IM. (Batch 277011). The 1st dose of RabAvert was on 7/3/01 and the 2nd was on 7/10/01. The pt continued to have left shoulder pain, joint pain, finger joint pain, left-sided neck pain, and is tender to touch on the left side of the body. There was no erythema at the injection site. A neurologic work-up was normal and the pt was afebrile. The pt complained of a headache, 3 days, post vax of the 2nd dose. It was reported by the PA, that as of 7/23/01, the condition of the pt was improving. The PA assessed this event as possibly related to the RabAvert injection.
This spontaneous report as received from a medical assistant refers to a 16 years old patient. The patient was vaccinated with the first dose of GARDASIL (dose, route and lot# not reported) on 13-FEB-2012, the second dose on 21-MAY-2012 and third dose on 20-JUL-2012. No adverse event. Additional information has been requested.
Weight loss; Viral like syndrome, does not go away; This non-serious case was reported by a physician via call center representative and described the occurrence of weight loss in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included smoker (patient is a smoker) and chronic obstructive pulmonary disease (has COPD).   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced weight loss (Verbatim: Weight loss) and viral syndrome (Verbatim: Viral like syndrome, does not go away). The outcome of the weight loss and viral syndrome were not reported.   It was unknown if the reporter considered the weight loss and viral syndrome to be related to Shingrix.     It was unknown if the company considered the weight loss and viral syndrome to be related to Shingrix.   Additional Information: GSK receipt date: 21-MAR-2023 The reporter reported that she has a patient who claimed he had a Shingrix vaccine given in 2019 and since that time he has had weight loss, viral like syndrome that last for several months and did not go away.  The symptoms occurred year after year after year in the spring. The reporter reported she had not seen the patient very long and did not have him when he received Shingrix and developed these symptoms.
Nausea/vomiting began 2 1/2 hours after receiving vaccine. She also had a low-grade fever.
Delayed reaction at injection site; Arm Pain / the arm is painful; Itchy Arm; Moderate swelling; Red Arm; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE REACTION (Delayed reaction at injection site), PAIN IN EXTREMITY (Arm Pain / the arm is painful), VACCINATION SITE PRURITUS (Itchy Arm), VACCINATION SITE SWELLING (Moderate swelling) and VACCINATION SITE ERYTHEMA (Red Arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Delayed reaction at injection site), PAIN IN EXTREMITY (Arm Pain / the arm is painful), VACCINATION SITE PRURITUS (Itchy Arm), VACCINATION SITE SWELLING (Moderate swelling) and VACCINATION SITE ERYTHEMA (Red Arm). At the time of the report, VACCINATION SITE REACTION (Delayed reaction at injection site), PAIN IN EXTREMITY (Arm Pain / the arm is painful), VACCINATION SITE PRURITUS (Itchy Arm), VACCINATION SITE SWELLING (Moderate swelling) and VACCINATION SITE ERYTHEMA (Red Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sore arm; bad chills; extreme fatigue; low grade fever; This is a spontaneous report from a contactable consumer (patient).  A non-pregnant 59-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6202) via an unspecified route of administration, administered in right arm on 24Feb2021 15:30 (at the age of 59 years old) as dose 2, single for COVID-19 immunisation. Medical history was not reported. It was reported yes for known allergies. Concomitant medications included pantoprazole, pravastatin, and gabapentin. The patient previously received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. On 25Feb2021 09:00, the patient experienced sore arm, bad chills, extreme fatigue, low grade fever. The facility type vaccine was reported as school or student health clinic. There was no other vaccine in four weeks. Patient had no COVID prior vaccination and was not COVID tested post vaccination. There was no treatment received on the events. The outcome of the events was recovered on an unspecified date on 2021.   No follow-up attempts are possible. No further information is expected.
arm hurt so bad; arm seemed to have swollen a bit; water blister had formed over the injection site; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 24Jul2021 at 15:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic, morbid obese and COVID-19. The patient has known allergy to penicillin. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included metformin HCL (MANUFACTURER UNKNOWN) and ethinylestradiol, norgestimate (SPRINTEC) both taken for unknown indication from an unknown start date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Jul2021 the second day of shot at 13:15 the patient experienced her arm hurt so bad and it seemed to have swollen a bit so the patient took off the band aid and went to put another band aid on. She observed a water blister had formed over the injection site and did not want to pop it so had put another band aid over it. It had not gone down or away but it was only been a few days and the patient just wanted to know if it is normal cause as she did not see it in the paperwork as a side effect. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm hurt so bad, it seemed to have swollen a bit and water blister had formed over the injection site were not recovered at the time of the report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
redness, warmth started 1 day after immunization; only the menactra site was involved
6 to 8 hours after vaccine patient experience general malaise and swelling at injection site. Then starting the next day "pox" developed. He had a cluster on his neck and near both ears and random single ones over body. They came and went along with on and off general malaise for 3 weeks.
Lupus - lungs tight, cough/breathless out of nowhere, crushing headaches, vertigo, goop in nose and throat, extremely low (96s) body temp, shaking chills, sleep troubles, fatigue, seeing ?black spots?/almost passing out, balance off where had to lean against walls.  I am VERY fit, do high intensity workout, hike tall mtns 15-20 mi day hikes and never get sick.  Had these cycling symptoms the DAY I got the second vax after just minimal arm ache with the first vax.  I had newer job as mortgage lender - working 45-50 hrs on phone 9-10 hrs a day selling loans company wanted at least 150 calls a day - high stress and pressure.  Have been on medical leave since this started as no way can work; get awful cough fits if even talk for a few mins and memory gets like a sieve and I have gotten disoriented in my own home.  It is very disabling and I was FINE before and am VERY durable.
The morning after receiving the vaccine, I began to develop a fever, chills and fatigue, along with soreness at the injection site. I had taken my temperature throughout the day with a Tmax of 101 F,  which broke ~36 hours after receiving the vaccine. No additional symptoms were experienced (diarrhea, nausea, vomiting, etc.)
sharp tingling sensation from upper arm to fingers along with pain and tenderness; sharp tingling sensation from upper arm to fingers along with pain and tenderness; complained of pain; it was very difficult to move her arm; Information has been received from a medical assistant referring to a 27 years old female patient. The patient's historical conditions included anxiety and depression. The patient's concurrent conditions included chronic pain and allergy to amoxicillin, cephalexin, penicillin (unspecified) and potassium (unspecified). The patient's concomitant therapies included albuterol (VENTOLIN INHALER), hydrochlorothiazide, metoprolol (reported as metaprolol), diclofenac and methylprednisolone (MEDROL).  On unknown dates, the patient was vaccinated with the first and second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) in left deltoid. The patient tolerated the doses of vaccine well. On 17-JAN-2020, the patient was vaccinated with the third dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (0.5 milliliter once, lot# S026372, expiration date of 01-APR-2022, strength was unknown) intramuscularly in right deltoid for human papilloma virus (HPV) prevention.   On 17-JAN-2020, at the time of vaccination, the patient complained of pain and was offered an ice pack and ibuprofen which she declined. The patient later that day reported to urgent care and was then referred back to the office. The patient was seen in the office on 24-JAN-2020 where no redness or swelling was detected at injection site but there were complaints of sharp tingling sensation from upper arm to fingers along with pain and tenderness. The patient called back to office on 03-FEB-2020 with continued complaints that it was very difficult to move her arm, discomfort although the arm was warm, not numb. The patient did not recover from the events. No treatment was given for the events. The nurse practitioner referred patient to a neurologist.   The relationship between the events and HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) was unknown.
Shortly after - brain fog  Two days of headache,  extreem fatigue,  chills  Symptoms ended - Feb. 12th around 3am  I was too weak to report this earlier.
Pain in arm evening of shot; Nov. 24th went to family doctor w/ pain radiating from vaccine location down arm - numbness in index finger & thumb - received steroids. After a week, went back for physical therapy - made worse. So went to orthopedic clinic. MRI - Dec 26 - results showed pocket at area of shot - fluid at surface of bone.
lightheadedness; Fever 100.2; body aches; Headache; Upset stomach; This is a spontaneous report from a contactable other health professional (patient).  A 59-year-old female patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number EL1284), in a hospital intramuscularly on 13Jan2021 at 09:45 at 59-years-old at a single dose for COVID-19 immunization.  Medical history included sarcoidosis from 2006 to an unknown date, breast cancer from 2006 to an unknown date, depression from an unknown date and unknown if ongoing, migraines from an unknown date and unknown if ongoing, reflux from an unknown date and unknown if ongoing, asthma from an unknown date and unknown if ongoing.  Concomitant medications included krill oil (MANUFACTURER UNKNOWN), colecalciferol (D3), zinc (MANUFACTURER UNKNOWN), chondroitin sulfate, glucosamine sulfate (MANUFACTURER UNKNOWN), gemfibrozil (MANUFACTURER UNKNOWN) , omeprazol [omeprazole] (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), almotriptan malate (MANUFACTURER UNKNOWN), acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE), albuterol [salbutamol] (MANUFACTURER UNKNOWN), prednisone (MANUFACTURER UNKNOWN), senior vitamin (MANUFACTURER UNKNOWN), "tension migraine" (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unspecified date to an unspecified date; "meticore" (MANUFACTURER UNKNOWN) taken for weight loss from an unspecified date to an unspecified date .  The patient previously took nystatin (MANUFACTURER UNKNOWN), cefalexin (KEFLEX), hydrocodone bitartrate paracetamol (VICODIN), LEVOFLOXACIN (LEVAQUIN) and experienced drug allergy from an unspecified date to an unspecified date. The patient previously received the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; first dose at 10:00, intramuscularly in the right arm-Lot Number EL1284) for COVID-19 immunization on 22Dec2020 at 59-years-old. On 16Jan2021 at 11:15, the patient experienced: lightheadedness, fever 100.2, body aches, headache, upset stomach. There was no treatment received. The patient underwent lab tests and procedures which included body temperature: 100.2 on 16Jan2021.  The clinical outcome of the events was recovered in Jan2021. The patient did not receive another vaccine within four weeks of the bnt162b2. The patient did not have COVID prior to the vaccination. The patient was not tested for COVID post vaccination.
3rd dose of GARDASIL administered on 6/30/08. Patient's mother called (4/1/08) states patient experienced 100 temperature body aches, shortness of breath and nausea after they arrived home.
17 year old patient  was scheduled  to receive a second COVID19 (Moderna Vaccine).  VAERS report was initially completed for 1st unintentional COVID19 vaccination administration on  5/23/21.  Second COVID19 (Moderna Vaccine) was given per  parent/guardian approval and clinical director approval per conditional approval.
Patient had uterine leiomyoscarcoma 1999 with pulmonary metastasis. Patient received her second cycle of her cheo-taxotere and gemzar in 9/28/04 and had a flu vaccine 9/30. 10/8 developed flu-like symptoms which include cough, fatigue, and myalgia, and questionable fever. 10/9 increased weakness that she was unable to walk around the home. 10/10 reported improvement and also reported taking Aleve, Advil, Tylenol, and Robitussin. 10/11 continued to have difficulties in walking without help but her cold symptoms resolved. Patient also noted minor transient blurred vision which resolved within 30 minutes and also anxiety. 10/12 admitted to ICU through ED on wheelchair when her Hgb was found to be 4.4. Discharge Summary received on 11/17/2004 states pt experienced anemia.  Medical Record received on 11/17/2004 states pt experienced dyspnea and hemolytic anemia.
This spontaneous report as received from a nurse refers to a 6 months 26 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
No adverse event; Maternal exposure during breast feeding; This spontaneous case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during breast feeding) and NO ADVERSE EVENT (No adverse event) in a 42-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS5051C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Nov-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 28-Nov-2022, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during breast feeding). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). On 28-Nov-2022, MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during breast feeding) had resolved. At the time of the report, NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during breast feeding).    Concomitant and treatment medications were not reported.   Reporter did not allow further contact
No adverse event; Vaccine administered after beyond use date 07-Jul-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 2-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022).    No concomitant medication was reported.  The vaccine beyond use date was 07Jul 2022.  No treatment information was provided.
Breakthrough case admission after three doses Moderna 4/2/21 Lot# 025B21A Moderna 4/30/21 Lot# 005C21A Moderna 11/9/21 Lot# 933903
1 of 2 pts vaxed from the same lots exp urticarial rash following immun w/Tetramune/OPV; pt recovered;
Developed syncope within 10 minutes of receiving GARDASIL. Bradycardic and hypotensive.
Patient received vaccine on the 17th and called the pharmacy on the 21st, complaining of symptoms beginning the night before (the 20th). Symptoms included difficulty moving/lifting arm and grasping objects in hand, painful (takes her 'breath away' when she tries to move arm), bruise, swollen elbow, possible bump on arm.
Client got his second dose of Hep A and 3rd dose of Hep B to soon.
I woke up in my sleep scratching myself all over my body. The left side of my face was swollen.
Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 08-Aug-2022; No adverse event; Patients were administered with Moderna COVID-19 Vaccine after 30-day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients were administered with Moderna COVID-19 Vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 08-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 2-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 08-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients were administered with Moderna COVID-19 Vaccine after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 08-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients were administered with Moderna COVID-19 Vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 08-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patients were administered with Moderna COVID-19 Vaccine after 30-day use by date) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 08-Aug-2022). No concomitant product use was reported. The number of doses/vials -around 50 doses from 5 vials. On 08-Jul-2022 the vials were initially stored in the refrigerator. The vaccines were administered from the 07-Aug-2022 until the 11-Aug-2022 Vial did not undergone any temperature excursions. The healthcare professional was not aware of any symptoms for any patient after the vaccine was given. No treatment information was provided.
Painful left arm to the point I had trouble undressing & dressing myself, lasting about  24 hrs. with it gradually getting better. Symptoms did go away after a full 48 hrs.   My Range of Motion was  limited. Fatigue,  chills,  N&V during the night
Spouse notified pharmacy (9/4/12) that patient began experiencing neck pain on night of 8/17/12. Progressed into breathing issues, ER, intubation, and patient is still currently in ICU.
I just got injected with Moderna and I'm noticing that I got the runs and a few chills; I just got injected with Moderna and I'm noticing that I got the runs and a few chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (I just got injected with Moderna and I'm noticing that I got the runs and a few chills) and CHILLS (I just got injected with Moderna and I'm noticing that I got the runs and a few chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (I just got injected with Moderna and I'm noticing that I got the runs and a few chills) and CHILLS (I just got injected with Moderna and I'm noticing that I got the runs and a few chills). At the time of the report, DIARRHOEA (I just got injected with Moderna and I'm noticing that I got the runs and a few chills) and CHILLS (I just got injected with Moderna and I'm noticing that I got the runs and a few chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were mentioned. Treatment medications not provided